Key takeaways
The dosage of oral semaglutide for weight loss is 25 mg once daily, according to clinical trials of the “Wegovy pill,” which is awaiting FDA approval.
Oral semaglutide dosing starts low to help your body adjust. The dose goes up each month until you reach the dosage recommended by your prescriber.
Take semaglutide tablets on an empty stomach, then wait 30 minutes before you eat, drink, or take other pills.
Here's what we'll cover
Here's what we'll cover
Here's what we'll cover
Key takeaways
The dosage of oral semaglutide for weight loss is 25 mg once daily, according to clinical trials of the “Wegovy pill,” which is awaiting FDA approval.
Oral semaglutide dosing starts low to help your body adjust. The dose goes up each month until you reach the dosage recommended by your prescriber.
Take semaglutide tablets on an empty stomach, then wait 30 minutes before you eat, drink, or take other pills.
Is there an oral semaglutide dosing option for weight loss yet? Not yet, but it should be coming soon.
As of publication, new oral semaglutide for weight loss (aka the Wegovy pill) is waiting approval from the US Food and Drug Administration (FDA).
“Wegovy pill” may be approved soon, offering an option for people interested in weight loss pills but not injections. Keep reading for a breakdown of the oral semaglutide dosage schedule for Rybelsus vs. Wegovy pill, plus the semaglutide oral dosing schedule used in clinical trials for weight loss.
Oral semaglutide for weight loss dosage chart
Semaglutide dosage for weight loss typically involves a once-weekly injection. The up-and-coming oral version is taken once daily. And the dose that’s effective for losing substantial weight is higher than what’s currently available as Rybelsus (a semaglutide tablet approved for type 2 diabetes).
Once the FDA approves oral semaglutide for weight loss, they’ll publish the full prescribing information, which will include the recommended dosage of Wegovy pill. For now, the oral semaglutide weight loss dosage chart below is based on clinical trial data.
Comparing oral semaglutide dosage: Rybelsus vs. Wegovy pill
| Rybelsus (R1 formulation) | Rybelsus (R2 formulation) | Wegovy pill* |
|---|---|---|---|
Dosage strengths | 3 mg, 7 mg, 14 mg | 1.5 mg, 4 mg, 9 mg | 3 mg, 7 mg, 14 mg, 25 mg |
Starting dosage | 3 mg once daily (days 1-30) | 1.5 mg once daily (days 1-30) | 3 mg once daily (weeks 1-4) |
Escalation dosage(s) | 7 mg once daily (days 31-60**) | 4 mg once daily (days 31-60**)
| 7 mg once daily (weeks 5-8) then 14 mg once daily (weeks 9-12) |
Maintenance dosage | 7 mg or 14 mg once daily | 4 mg or 9 mg once daily | 25 mg once daily |
Maximum dosage | 14 mg once daily | 9 mg once daily | 25 mg once daily |
*Pending FDA approval; information about Wegovy pill in table is based on the OASIS 4 clinical trial
**Some people may stay on this Rybelsus dose long-term if it works well to control blood sugar levels.
Oral semaglutide dose for weight loss
The target dosage of oral semaglutide for weight loss is 25 mg once daily, assuming the dosage from clinical trials receives approval from the FDA. Official dosing instructions aren’t yet published.
Here’s how participants took oral semaglutide in the OASIS 4 phase 3 trial:
Starting dosage: 3 mg once daily for the first four weeks to help the body adjust
Step-up dosages: the dose increased every four weeks — to 7 mg, then 14 mg, and finally 25 mg. Most people reached the maintenance dose after completing 12 weeks of gradual escalation.
Maintenance dosage: 25 mg once daily. Those who couldn’t tolerate 25 mg stayed on a lower dose and tried increasing again later under medical guidance.
Maximum dosage: 25 mg once daily. This trial used a maximum dose of 25 mg. On average, people taking oral semaglutide 25 mg daily lost 13.6% of their body weight after 64 weeks.
Earlier clinical trials tested higher doses and saw even better weight loss results. In the OASIS 1 trial, people who took oral semaglutide 50 mg once daily lost about 15% of their body weight after 68 weeks. However, 92% experienced side effects, suggesting 50 mg may be too difficult for many people to tolerate.
Novo Nordisk, the maker of semaglutide, has requested FDA approval for the 25 mg dose. It’s not yet clear whether higher doses will be included in the label or prescribed off label once the drug becomes available.
The semaglutide oral dosage for weight loss is higher than what’s currently available. Right now, Rybelsus is the only oral semaglutide on the market.
It’s FDA-approved for controlling blood sugar levels and lowering the risk of serious cardiovascular problems in adults with type 2 diabetes. Rybelsus isn’t commonly prescribed for weight loss but some people lose a modest amount of weight while taking it.
Like other GLP-1 medications, Rybelsus starts at a low dose and gradually increases over time. It comes in two formulations: the original R1 and newer R2.
Here’s the typical dosing schedule for Rybelsus R1:
Starting dosage: 3 mg once daily for the first 30 days to help the body adjust
Step-up dosage: increase to 7 mg once daily for the next 30 days, then may increase to 14 mg once daily thereafter
Maintenance dosage: typically 14 mg once daily but some people stay on 7 mg once daily if it works well for controlling their blood sugar levels
Maximum dosage: 14 mg once daily
Here’s the typical dosing schedule for Rybelsus R2:
Starting dosage: 1.5 mg once daily for the first 30 days to help the body adjust
Step-up dosage: increase to 4 mg once daily for the next 30 days, then may increase to 9 mg once daily thereafter
Maintenance dosage: typically 9 mg once daily but some people stay on 4 mg once daily if it works well for controlling their blood sugar levels
Maximum dosage: 9 mg once daily
Some people may need lower doses or slower titration schedules. Be sure to check in with your healthcare provider before making changes.
How to take oral semaglutide for weight loss
Here’s how to take oral semaglutide based on the current Rybelsus instructions and steps used in clinical trials:
1. Take it once a day in the morning, on an empty stomach. Choose a consistent time each morning before eating or drinking anything.
2. Swallow the tablet whole with a small sip of water — no more than 4 ounces (120 mL). This needs to be plain water. Don’t use coffee, juice, or any other liquid, and don’t crush, cut, or chew the tablet.
3. Wait at least 30 minutes before swallowing anything else. This gives your body time to absorb the drug properly. This means no food, no water, no other beverages, and no other oral medications for 30 minutes after you take oral semaglutide.
Having anything in your stomach can make oral semaglutide less effective, so follow these steps carefully. This routine helps your body absorb the medicine and get its full benefit.
What to do if you miss a dose of oral semaglutide
If you miss a dose of oral semaglutide, just skip it that day. Then take your regular dose the next morning as usual. Don’t double up or take an extra tablet to make up for the missed dose.
The following tips can help you stay on track:
Set a daily alarm to remind you to take your dose first thing in the morning.
Put a big reminder note somewhere you can’t miss, such as on your coffeemaker or kitchen counter.
Medications with strict rules can be tricky to get used to, and you may wonder if it’s OK to bend the rules. Examples of common questions:
“Can I still take it if I already had breakfast or coffee?”
“Can I take it with black coffee?”
“Can I take it with my morning dose of levothyroxine (Synthroid)?”
For all of these questions, the answer is no.
It must be taken on an empty stomach. Any food or liquid can interfere with how your body absorbs the medication, making it much less effective.
If you miss a dose of oral semaglutide (Rybelsus or Wegovy pill), you’ll need to wait until the next morning to take your next dose (unless directed otherwise by your prescriber).
If you miss or forget to take oral semaglutide often, tell your healthcare provider, especially if you’re not losing weight or seeing results. They may suggest switching to an injectable version.
Semaglutide injections (such as Wegovy) are only given once a week and can lead to greater weight loss. For example, patients getting care through Ro lost an average of 16.6% of their body weight on injectable semaglutide in 68 weeks.
Bottom line
Oral semaglutide may offer a once-daily, needle-free option for managing weight. For now, only Rybelsus (approved for type 2 diabetes) is available. But a higher-dose version may be approved soon as the Wegovy pill. Here’s a recap of what we’ve covered on oral semaglutide dosing:
Start low, go slow. Doses increase gradually to help your body adjust and limit side effects. Your healthcare provider will work with you to find the oral semaglutide dosage that suits your needs and goals.
Take it on an empty stomach: Swallow oral semaglutide first thing in the morning with no more than 4 ounces of plain water (read: not coffee).
Wait 30 minutes before eating, drinking, or other pills. This helps your body absorb the medicine properly.
Follow the routine: Taking oral semaglutide with food or extra fluid can make it ineffective. For best results, take it exactly as instructed.
Frequently asked questions (FAQs)
Is 2mg of oral semaglutide enough?
No, 2 mg is not a standard dose of oral semaglutide (Rybelsus). Rybelsus is taken once daily in maintenance doses ranging from 4 mg to 14 mg. The not-yet-approved oral semaglutide for weight loss (Wegovy pill) has a maintenance dosage of 25 mg daily, according to trials.
What is the dosing for oral semaglutide?
The dosing for oral semaglutide is once daily. The exact dose largely depends on whether it’s being used for type 2 diabetes or weight loss (current off-label use, but a higher dose for this purpose may soon be available).
Oral semaglutide dosing for type 2 diabetes (Rybelsus):
Starting dose: 3 mg once daily (R1 formulation) or 1.5 mg once daily (R2 formulation)
Maintenance dose: 7 mg or 14 mg once daily (R1 formulation) or 4 mg or 9 mg once daily (R2 formulation)
Maximum dose: 14 mg once daily (R1 formulation) or 9 mg once daily (R2 formulation)
Oral semaglutide dosing for weight loss (potential Wegovy pill)*:
Starting doses: 3 mg once daily (weeks 0 to 4), then increase to 7 mg (weeks 5 to 8), then increase to 14 mg (weeks 9 to 12)
Maintenance dose: 25 mg once daily
Maximum dose: 25 mg once daily or, if approved in future, 50 mg
*based on clinical trials
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
Wegovy Important Safety Information: Read more about serious warnings and safety info.
References
Aroda, V. R., Aberle, J., Bardtrum, L., et al. (2023). Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial. Lancet (London, England), 402(10403), 693–704. doi: 10.1016/S0140-6736(23)01127-3. Retrieved from https://pubmed.ncbi.nlm.nih.gov/37385279/
ClinicalTrials.gov. (2025). Research study looking at how well semaglutide tablets taken once daily works in people who have a body weight above the healthy range (OASIS 4). Retrieved Nov. 12, 2025 from https://clinicaltrials.gov/study/NCT05564117
Hughes, S. & Neumiller, J. J. (2020). Oral Semaglutide. Clinical Diabetes, 38(1), 109–111. doi: 10.2337/cd19-0079 Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC6969659/
Knop, F. K., Aroda, V. R., do Vale, R. D., et al. (2023). Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet (London, England), 402(10403), 705–719. doi: 10.1016/S0140-6736(23)01185-6. Retrieved from https://pubmed.ncbi.nlm.nih.gov/37385278/
Novo Nordisk. (2025). Press Release: FDA accepts filing application for oral semaglutide 25 mg, which if approved, would be the first oral GLP-1 treatment for obesity. Retrieved from https://www.novonordisk-us.com/media/news-archive/news-details.html?id=915988
Tchang, B., Broffman, L., & Manalac, R., et al. (2025). Real-World Evidence on Weight Loss and Safety With Semaglutide in Obesity Telehealth: A Large Retrospective Cohort Study. Obesity, 0, 1-9. doi: 10.1002/oby.70120 Retrieved from https://onlinelibrary.wiley.com/doi/ftr/10.1002/oby.70120
U.S. Food and Drug Administration (FDA). (2025). Prescribing Information: Rybelsus (semaglutide) tablet, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213051s024,s028s029lbl.pdf
Wharton, S., Lingvay, I., Bogdanski, P., et al. (2025). Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. The New England Journal of Medicine, 393(11), 1077–1087. doi: 10.1056/NEJMoa2500969. Retrieved from https://www.nejm.org/doi/full/10.1056/NEJMoa2500969















